IP Library Granted Patent US 7,229,615
Granted Patent B2
US 7,229,615 · App. 11/248,552 · Granted Jun 12, 2007

Method for the purification, recovery, and sporulation of cysts and oocysts

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,229,615
App. No.
11/248,552
Granted
Jun 12, 2007
Kind
B2
Abstract

A vaccine for in ovo vaccination against avian coccidiosis produced by a method including obtaining the coccidial oocysts from a fecal suspension, homogenizing the fecal suspension, separating the oocysts from the fecal debris by either salt flotation using sodium sulfate or gas flotation using air, sporulating the oocysts using hydrogen peroxide and air sparging, bleaching the sporulated oocysts, washing the bleached oocysts, concentrating the sterile washed oocysts and combining the concentrates of various species of coccidial oocysts, and producing a vaccine. The method in whole or in part can be applied to other kinds of encysted protozoa to produce vaccines for various types of animals.

Claims (37)

1. A method for the sporulation of Eimeria oocysts, comprising:

forming an aqueous suspension of the oocysts with water and hydrogen peroxide, wherein the hydrogen peroxide is present in an amount sufficient to eliminate undesirable non-protozoan microbiological growth; and

aerating the aqueous suspension to sporulate the oocysts.

2. The method of claim 1 , wherein the aqueous suspension is aerated for a time period greater than about 40 hours such that the aqueous suspension during aeration has a dissolved oxygen level greater than about 80% of the saturation level at a temperature of about 22° C. to about 32° C. and with an agitation level sufficient to adequately suspend all the solids.

3. The method of claim 1 , wherein the aqueous suspension is incubated for a time period up to about 72 hours.

4. The method of claim 1 , wherein the aqueous suspension is incubated for a time period between about 40 and 72 hours.

5. The method of claim 1 , wherein the aqueous suspension comprises an oocyst concentration of about 10 4 to about 10 6 oocysts/ml and an initial hydrogen peroxide concentration of about 1,000 to about 20,000 mg/l.

6. The method of claim 1 , wherein the Eimeria oocysts are selected from the group consisting of oocysts from Eimeria maxima, Eimeria mitis, Eimeria tenella, Eimeria acervulina, Eimeria brunetti, Eimeria necatrix, Eimeria praecox , and combinations thereof.

7. A method for the purification, recovery and sporulation of Elmeria oocysts, comprising: separating the oocysts from a first suspension comprising the oocysts: and sporulating the separated oocysts by the method of claim 1 .

8. The method of claim 7 wherein the Eimeria oocysts are selected from the group consisting of oocysts from Eimeria maxima, Eimeria mitis, Eimeria tenella, Eimeria acervulina, Eimeria brunetti, Eimeria necatrix, Eimeria praecox , and combinations thereof.

9. The method of claim 7 , wherein separating the oocysts is accomplished by a salt flotation process.

10. The method of claim 9 wherein the salt flotation process comprises:

preparing an admixture comprising the oocysts and the salt;

centrifuging the slurry and recovering a supernatant therefrom;

forming a dilution of the supernatant and centrifuging the dilution; and

recovering the concentrate from the centrifuged dilution.

11. The method of claim 9 , wherein the salt comprises sodium sulfate, potassium sulfate, magnesium sulfate, sodium phosphate, potassium phosphate, magnesium phosphate, sodium acetate, potassium acetate, magnesium acetate, or mixtures thereof.

12. The method of claim 11 , wherein the salt comprises magnesium sulfate.

13. The method of claim 11 , wherein the salt comprises sodium sulfate.

14. The method of claim 7 , wherein separating the oocysts is accomplished by a gas flotation process which comprises:

adjusting the first suspension to a pH sufficient to affect adhesion between bubbles of the gas in the suspension and the encysted protozoa;

conditioning the pH adjusted suspension by adding a sufficient amount of a surface active agent compound to selectively coat particles in the suspension and a sufficient amount of a heteropolar compound to produce a stable froth;

passing the conditioned suspension through at least one gas flotation cell; and

recovering the encysted protozoa from the gas flotation cell.

15. The method of claim 7 , further comprising:

adding a bleaching agent to the sporulated or sporulating oocysts in an amount sufficient to inactivate residual microorganisms and eliminate residual organic matter; and

bleaching the sporulated or sporulating oocysts.

16. The method of claim 15 , wherein the bleaching agent is hydrogen peroxide.

17. The method of claim 16 , wherein the bleaching is conducted concurrently with the sporulation.

18. The method of claim 16 , wherein the hydrogen peroxide is initially present in an amount from about 2,000 to about 20,000 mg/l.

19. The method of claim 15 , wherein the bleaching agent is sodium hypochlorite present in an amount from about 5,000 to about 10,000 parts per million free available chlorine, ozone present in an amount up to about 3% in air, or combinations thereof.

20. The method of claim 15 , further comprising washing the bleached oocysts by cross-flow membrane filtration to decrease the residual bleaching agent concentration to an acceptable level.

21. The method of claim 20 , wherein the bleached and washed oocyst suspension has a concentration from about 1×10 6 to about 2.5×10 6 oocysts/ml, a maximum solids size of less than about 200 microns, and a salt content of less than about 0.9 percent.

22. The method of claim 21 , further comprising:

concentrating the bleached and washed oocysts into a sterile concentrate;

combining sterile concentrates of one or more species of oocysts into a combined concentrate; and

packaging the combined concentrated under sterile conditions.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 18, 2016
From: ZOETIS SERVICES LLC
To: HUVEPHARMA EOOD
Reel/Frame 038176/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2015
From: ZOETIS LLC
To: ZOETIS SERVICES LLC
Reel/Frame 035651/0817 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 11, 2013
From: PFIZER INC.
To: AH USA 42 LLC
Reel/Frame 029609/0336 →